Product Information
SODIUM BICARBONATE 8.4% VIAL is a generic product labeled by Exela Pharma Sciences, LLC, priced at $0.1540 per ML under NDC 51754500104. Its NADAC has been published 199 times since Dec 14, 2022.
FDA first approved this application on Jun 20, 2019. Its Orange Book therapeutic-equivalence code is AP.
Strength
84 mg/mL
Manufacturer
Exela Pharma Sciences, LLCNDC
51754500104
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
7/22/2026
Active Ingredients
SODIUM BICARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA211091FDA Approved
6/20/2019
TE Code
AP
On Market Since
8/1/2019
Pharmacological Classes
Price Statistics
The NADAC for SODIUM BICARBONATE 8.4% VIAL has been published 199 times since Dec 14, 2022, and over the history we have for it it has declined 15.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1540 per ML |
|---|---|
| All-time high | $0.2082 (Apr 16, 2025) |
| All-time low | $0.1540 (Apr 22, 2026) |
| 52-week high | $0.1721 |
| 52-week low | $0.1540 |
| Median price | $0.1683 |
| Average price | $0.1709 |
| Largest weekly change | +11.4% (Feb 19, 2025) |
| Weeks tracked | 199 |
| Tracking since | Dec 14, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exela Pharma Sciences, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SODIUM BICARBONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SODIUM BICARBONATE 8.4% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SODIUM BICARBONATE 8.4% VIAL, manufactured by Exela Pharma Sciences, LLC, is $0.1540 per ML (NDC 51754500104), effective Sep 30, 2026.
How has the price of SODIUM BICARBONATE 8.4% VIAL changed over time?
Over the history we have for it, the NADAC for SODIUM BICARBONATE 8.4% VIAL has declined 15.4%. It has been tracked across 199 weekly CMS publications since Dec 14, 2022.
What are the highest and lowest recorded NADAC prices for SODIUM BICARBONATE 8.4% VIAL?
Since Dec 14, 2022, the NADAC for SODIUM BICARBONATE 8.4% VIAL has ranged from a low of $0.1540 (Apr 22, 2026) to a high of $0.2082 (Apr 16, 2025), with a median of $0.1683 per ML.
Are there cheaper alternatives to SODIUM BICARBONATE 8.4% VIAL?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SODIUM BICARBONATE 8.4% VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures SODIUM BICARBONATE 8.4% VIAL?
SODIUM BICARBONATE 8.4% VIAL (NDC 51754500104) is labeled by Exela Pharma Sciences, LLC, and CMS classifies it as a generic product.